| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 46,377 | $253.05 | $11,735,856.35 | -34.5% | +6.0% | -25.1% | |
| May 10, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 2,700 | $105.11 | $283,794.24 | -0.2% | +2.3% | +44.3% | |
| May 10, 2024 | WST West Pharmaceutical Services Inc | Hofmann Thomas W | Director | Sell | 617 | $365.92 | $225,772.64 | -1.4% | -19.5% | -41.5% | |
| May 10, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 30,000 | $104.59 | $3,137,567.15 | -3.3% | +2.3% | +44.3% | |
| May 10, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 4,956 | $402.89 | $1,996,722.84 | -0.7% | -2.0% | -24.1% | |
| May 10, 2024 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 1,304 | $226.97 | $295,968.88 | -5.3% | -11.5% | -39.2% | |
| May 9, 2024 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 244 | $1.48 | $361.00 | -2.4% | +2.6% | -76.0% | |
| May 9, 2024 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 468 | $1.48 | $692.41 | -0.6% | +2.6% | -76.0% | |
| May 9, 2024 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,764 | $1.48 | $5,568.84 | -0.8% | +2.6% | -76.0% | |
| May 9, 2024 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 434 | $1.48 | $642.10 | -0.3% | +2.6% | -76.0% | |
| May 9, 2024 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 980 | $1.48 | $1,449.91 | -0.6% | +2.6% | -76.0% | |
| May 9, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 8,268 | $400.41 | $3,310,566.18 | -0.6% | -7.8% | -25.8% | |
| May 7, 2024 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President, CEO And Board Chair | Sell | 66,000 | $366.65 | $24,199,050.23 | -10.6% | -18.1% | -42.1% | |
| May 7, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 52,404 | $403.20 | $21,129,346.92 | -3.4% | -6.2% | -25.4% | |
| May 7, 2024 | XWEL Xwell, Inc. | Wizenberg Gaelle Sandra | Director | Buy | 299 | $1.84 | $551.15 | +299.0% | +2.2% | -54.8% | |
| May 6, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 23,323 | $24.64 | $574,678.72 | -29.7% | -10.5% | -31.9% | |
| May 6, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,336 | $24.72 | $156,625.92 | -2.4% | -10.5% | -31.9% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,311 | $37.13 | $85,816.67 | -1.3% | +28.7% | -4.8% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 4,163 | $37.13 | $154,588.84 | -0.8% | +28.7% | -4.8% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 910 | $37.13 | $33,791.94 | -1.0% | +28.7% | -4.8% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 132 | $37.13 | $4,901.69 | -0.3% | +28.7% | -4.8% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Banyai William81 | See Remark | Sell | 798 | $37.13 | $29,632.93 | -0.2% | +28.7% | -4.8% | |
| May 3, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 568 | $37.13 | $21,092.11 | -0.7% | +28.7% | -4.8% | |
| May 2, 2024 | DHR Danaher Corp /de/ | Spoon Alan G55 | Director | Sell | 708 | $243.58 | $172,454.64 | -0.6% | +12.3% | -19.4% | |
| May 2, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 16,330 | $401.33 | $6,553,671.28 | -1.0% | -2.2% | -22.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.